243 related articles for article (PubMed ID: 30605883)
1. Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function.
Brandt A; Nier A; Jin CJ; Baumann A; Jung F; Ribas V; García-Ruiz C; Fernández-Checa JC; Bergheim I
Redox Biol; 2019 Feb; 21():101092. PubMed ID: 30605883
[TBL] [Abstract][Full Text] [Related]
2. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444
[TBL] [Abstract][Full Text] [Related]
3. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
Baumann A; Jin CJ; Brandt A; Sellmann C; Nier A; Burkard M; Venturelli S; Bergheim I
Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235497
[TBL] [Abstract][Full Text] [Related]
4. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH).
Jin CJ; Sellmann C; Engstler AJ; Ziegenhardt D; Bergheim I
Br J Nutr; 2015 Dec; 114(11):1745-55. PubMed ID: 26450277
[TBL] [Abstract][Full Text] [Related]
5. Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine.
Brandt A; Hernández-Arriaga A; Kehm R; Sánchez V; Jin CJ; Nier A; Baumann A; Camarinha-Silva A; Bergheim I
Sci Rep; 2019 Apr; 9(1):6668. PubMed ID: 31040374
[TBL] [Abstract][Full Text] [Related]
6. GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease.
Baumann A; Burger K; Brandt A; Staltner R; Jung F; Rajcic D; Lorenzo Pisarello MJ; Bergheim I
Metabolism; 2022 Aug; 133():155233. PubMed ID: 35654114
[TBL] [Abstract][Full Text] [Related]
7. Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice.
Jung F; Lippmann T; Brandt A; Jin CJ; Engstler AJ; Baumann A
Eur J Nutr; 2020 Mar; 59(2):787-799. PubMed ID: 30879098
[TBL] [Abstract][Full Text] [Related]
8. Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis.
Sellmann C; Jin CJ; Degen C; De Bandt JP; Bergheim I
J Nutr; 2015 Oct; 145(10):2280-6. PubMed ID: 26246326
[TBL] [Abstract][Full Text] [Related]
9. Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase.
Rajcic D; Baumann A; Hernández-Arriaga A; Brandt A; Nier A; Jin CJ; Sánchez V; Jung F; Camarinha-Silva A; Bergheim I
Redox Biol; 2021 May; 41():101879. PubMed ID: 33550112
[TBL] [Abstract][Full Text] [Related]
10. Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non-alcoholic fatty liver disease.
Baumann A; Rajcic D; Brandt A; Sánchez V; Jung F; Staltner R; Nier A; Trauner M; Staufer K; Bergheim I
J Cell Mol Med; 2022 Feb; 26(4):1206-1218. PubMed ID: 35029027
[TBL] [Abstract][Full Text] [Related]
11. Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance.
Sánchez V; Brandt A; Jin CJ; Rajcic D; Engstler AJ; Jung F; Nier A; Baumann A; Bergheim I
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33809593
[TBL] [Abstract][Full Text] [Related]
12. Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis.
Sellmann C; Degen C; Jin CJ; Nier A; Engstler AJ; Hasan Alkhatib D; De Bandt JP; Bergheim I
Amino Acids; 2017 Jul; 49(7):1215-1225. PubMed ID: 28434046
[TBL] [Abstract][Full Text] [Related]
13. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
[TBL] [Abstract][Full Text] [Related]
14. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
Sellmann C; Jin CJ; Engstler AJ; De Bandt JP; Bergheim I
Eur J Nutr; 2017 Dec; 56(8):2519-2527. PubMed ID: 27496089
[TBL] [Abstract][Full Text] [Related]
15. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.
Schumacher-Petersen C; Christoffersen BØ; Kirk RK; Ludvigsen TP; Zois NE; Pedersen HD; Vyberg M; Olsen LH
J Transl Med; 2019 Apr; 17(1):110. PubMed ID: 30943987
[TBL] [Abstract][Full Text] [Related]
16. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I
J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700
[TBL] [Abstract][Full Text] [Related]
17. Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.
Rahman K; Desai C; Iyer SS; Thorn NE; Kumar P; Liu Y; Smith T; Neish AS; Li H; Tan S; Wu P; Liu X; Yu Y; Farris AB; Nusrat A; Parkos CA; Anania FA
Gastroenterology; 2016 Oct; 151(4):733-746.e12. PubMed ID: 27342212
[TBL] [Abstract][Full Text] [Related]
18. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
[TBL] [Abstract][Full Text] [Related]
19. Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice.
Sellmann C; Baumann A; Brandt A; Jin CJ; Nier A; Bergheim I
J Nutr; 2017 Nov; 147(11):2041-2049. PubMed ID: 28931589
[No Abstract] [Full Text] [Related]
20. Fortifying diet with rapeseed oil instead of butterfat attenuates the progression of diet-induced non-alcoholic fatty liver disease (NAFLD) and impairment of glucose tolerance.
Brandt A; Rajcic D; Jin CJ; Sánchez V; Engstler AJ; Jung F; Nier A; Baumann A; Bergheim I
Metabolism; 2020 Aug; 109():154283. PubMed ID: 32497536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
